Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: News Summary Dashboard

Pfizer reports data from Phase II multiple myeloma treatment trial neutral
PFE

Summary: Pfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO (elranatamab-bcmm) in patients with relapsed or refractory multiple myeloma (RRMM), showcasing an ORR of 61% and a complete response rate of 37.4%, with a median overall survival of 24.6 months reported in cohort A of the single arm trial.

Full article
2024-06-17T08:56:37Z
Booking Holdings Inc. (NASDAQ:BKNG) Shares Acquired by Integrated Advisors Network LLC somewhat bullish
BKNG BKNG

Summary: Integrated Advisors Network LLC increased its position in Booking Holdings Inc. by 5.1% during the fourth quarter, as per its recent 13F filing. Multiple other institutional investors and hedge funds have also adjusted their holdings of the company. Booking recently announced a quarterly dividend, with insiders engaging in buying and selling activities. Analysts have set new price targets, with a mix of hold, outperform, buy, and strong buy ratings.

Full article
2024-06-17T08:56:15Z
American Medtronic to establish presence in Serbia - bne IntelliNews somewhat bullish
MDT

Summary: Medtronic, an American medical technology giant, will establish operations in Serbia after signing a memorandum of understanding with the Ministry of Science, Technological Development and Innovation on June 14. This cooperation within the BIO4 Campus aims to strengthen the bio-economic startup ecosystem and enhance scientific-research collaboration in Serbia.

Full article
2024-06-17T08:54:29Z
Broadcom's Stock Split Isn't a Reason to Buy Shares: These 2 Reasons Are somewhat bullish
AVGO NVDA

Summary: Broadcom (AVGO) announced a 10-for-1 stock split on July 12, following a surge in its stock price post-earnings report. The split won't impact the company's overall value, which is around $780 billion. Beyond the stock split, Broadcom's positive outlook is supported by strong performance in its software segment and AI products.

Full article
2024-06-17T08:54:09Z
IBM and the All England Lawn Tennis Club Launch New Generative Ai Feature ... - MarketScreener neutral
IBM

Summary: IBM and The All England Lawn Tennis Club have introduced a new 'Catch Me Up' feature for the Wimbledon digital experience, leveraging match data with generative AI from IBM's watsonx platform to provide fans with player updates, stories, and analysis. Generative AI will also be used to enhance coverage across various matches, including wheelchair events, and part of the redesigned digital match centre known as IBM Slamtracker.

Full article
2024-06-17T08:51:25Z
Boeing Stock: Buy, Sell, or Hold? - Nasdaq somewhat bearish
BA SPR

Summary: Boeing's stock has declined more than 30% in 2024, but there are arguments for and against buying it. On one hand, it has an important position in the aviation industry and potential for growth; on the other hand, there are concerns about labor negotiations, cash drain from Spirit AeroSystems, and the lack of a new CEO.

Full article
2024-06-17T08:40:32Z
Kuo: Apple Watch Series 10 to feature larger display and thinner chassis, approaching Ultra ... neutral
AAPL

Summary: Analyst Ming-Chi Kuo predicts that the upcoming Apple Watch Series 10 will have a thinner chassis and larger displays, increasing from the current 41mm and 45mm sizes to about 45mm and 49mm, respectively. The new form factors would make the smallest watch as big as the current larger Series 9, while the new bigger model would approach the Apple Watch Ultra screen size. Kuo also mentions a dark titanium color option for the new Apple Watch Ultra.

Full article
2024-06-17T08:39:57Z
NYSE American to begin delisting NUBURU - Semiconductor Today somewhat bearish
BURU

Summary: NYSE American has begun delisting NUBURU Inc due to the selling price of the common stock falling below $0.10, NUBURU plans to appeal the delisting, trading in the firm's common stock has been suspended.

Full article
2024-06-17T08:38:26Z
Apple, PayPal Send Mixed Messages as CE 100 Index Slips 0.7% - PYMNTS.com neutral
AAPL AFRM PYPL V ADBE ZM CRWD

Summary: Apple announced new features at its developers conference, including expanding Apple Pay beyond smartphones, which had a positive impact on Apple shares and Enablers segment, but PayPal shares declined. Visa's rally and Adobe's strong performance offset some losses in CE 100 Index.

Full article
2024-06-17T08:38:16Z
Raytheon (RTX) Wins $353.9M Deal for LTAMDS Radar Prototypes - Yahoo News NZ very bullish
RTX LMT LHX NOC

Summary: Raytheon Technologies Corporation RTX has secured a $353.9 million contract to provide additional LTAMDS radar prototypes for the U.S. Army, boosting its revenue prospects. The demand for military radars is expected to rise in the long term, benefiting RTX and other defense majors like Lockheed Martin, L3Harris Technologies, and Northrop Grumman.

Full article
2024-06-17T08:35:17Z
Microsoft's Japan chief sees country accelerating its use of AI - The Japan Times somewhat bullish
JPXN MSFT

Summary: Japan has been embracing new artificial intelligence tools which have the potential to accelerate its economy and tech sector further, especially after catching up during the pandemic.

Full article
2024-06-17T08:31:39Z
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Teachers Retirement System of The ... somewhat bullish
NASDAQ:GILD

Summary: Slagle Financial LLC increased its position in Gilead Sciences by 99.0% during the 4th quarter, holding $4,142,000 worth of the company's stock. Other institutional investors also made changes to their positions in the company. Insider selling of 2,000 shares occurred, and the company declared a quarterly dividend of $0.77 per share. Multiple analyst ratings changes have been reported on the stock recently.

Full article
2024-06-17T08:27:47Z
Boeing Stock: Buy, Sell, or Hold? | The Motley Fool somewhat bearish
BA SPR

Summary: Boeing's stock is facing challenges despite its crucial position in the aviation industry and potential for growth, with concerns over labor negotiations, potential cash drain from supplier Spirit AeroSystems, and the need for a new CEO.

Full article
2024-06-17T08:27:18Z
Disney and Pixar's Inside Out 2 makes record opening weekend - BBC very bullish
DIS

Summary: Pixar's Inside Out 2 breaks box office records with a weekend opening of $295m worldwide, surpassing all-time animated film global opening record. The movie's success provides a much-needed boost to the cinema industry, which has seen lacklustre box office numbers this year.

Full article
2024-06-17T08:25:49Z
6,770 Shares in Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) Acquired by V ... somewhat bullish
CCEP

Summary: V Square Quantitative Management LLC purchased a new stake in Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) during the fourth quarter. Several other hedge funds have also bought shares of the stock. Analysts have mostly given a buy rating to the company, with a consensus price target of $76.44. Coca-Cola Europacific Partners opened at $74.05. The business announced a semi-annual dividend of $0.79 per share.

Full article
2024-06-17T08:22:24Z
Honeywell's new automation software promises to optimize large-scale battery manufacturing - somewhat bullish
HON

Summary: Honeywell launches Battery Manufacturing Excellence Platform (Battery MXP) powered by AI to optimize operation of large-scale battery manufacturing, reducing costs and waste.

Full article
2024-06-17T08:20:37Z
Palbociclib by Pfizer for Metastatic Pancreatic Cancer: Likelihood of Approval neutral
PFE

Summary: GlobalData tracks drug-specific phase transition and likelihood of approval scores for various indications like breast cancer, renal cell carcinoma, head and neck squamous cell carcinoma, and more. Pfizer, a biopharmaceutical company, offers products to treat various conditions including cancer. Palbociclib (Ibrance) is a cyclin-dependent kinase (CDK) inhibitor under development for multiple types of cancer.

Full article
2024-06-17T08:18:10Z
Daxdilimab by Amgen for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus ... neutral
AMGN

Summary: GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company, and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Amgen is a biotechnology company that develops and markets innovative human medicines for various serious diseases.

Full article
2024-06-17T08:11:44Z
Deutsche Bank reveals its appeal as managing directors rush to join - eFinancialCareers somewhat bullish
DB

Summary: Deutsche Bank has seen a significant increase in senior hires in recent months and a growth in revenues, particularly in M&A and capital markets. The bank's appeal is on the rise with a doubling stock price over the last five years, higher salaries, and generous bonuses. Despite positive developments, concerns exist about the fixed income sales and trading business which accounts for a large portion of revenues.

Full article
2024-06-17T08:10:53Z
All for One Group SE: Release of a capital market information - EQS News neutral
A1OS

Summary: All for One Group SE announces the completion of its Share Buyback Programme with a total of 81,997 shares repurchased. The program was extended in October 2023.

Full article
2024-06-17T08:08:57Z
Ford: electric fleet transition needs ecosystem solutions - Automotive World neutral
FORD

Summary: Europe's commercial fleets are under pressure to transition to electric vehicles due to a looming deadline for the end of internal combustion engine sales and the increase in low-emission zones in city centers. Ford Pro Europe emphasizes the importance of building an ecosystem around electric vehicles, including software, finance, and charging solutions.

Full article
2024-06-17T07:59:53Z
Cisco to focus on security, AI projects in new Taiwan investment - CNBC neutral
CSCO

Summary: Cisco is planning to focus on security and AI projects in new investment in Taiwan and Vietnam.

Full article
2024-06-17T07:59:29Z
Adakitug by Bristol-Myers Squibb for Melanoma: Likelihood of Approval neutral
BMY

Summary: GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Full article
2024-06-17T07:58:26Z
Intel Arc Graphics driver update answers the age-old question, 'Can it play Crysis?' somewhat bullish
INTC

Summary: Intel releases a new driver for Arc graphics cards adding support for new titles like Elden Ring's expansion and offering performance improvements for legacy games like Crysis and Chivalry 2.

Full article
2024-06-17T07:58:26Z
Apple Intelligence may be reason why OpenAI wants Microsoft to work with archrival Oracle somewhat bullish
MSFT ORCL OPENAI

Summary: Oracle, Microsoft, and OpenAI are collaborating to extend the Microsoft Azure AI platform to Oracle Cloud Infrastructure (OCI) to meet the rising demand for AI. Apple's focus on AI in its upcoming products like iOS 18 and macOS Sequoia is likely spurring this collaboration. OCI's AI capabilities, including Nvidia GPU instances, cater to various AI applications.

Full article
2024-06-17T07:49:13Z
MoonPay Announces PayPal Support For EU and UK Users - Altcoin Buzz somewhat bullish
PayPal MOON

Summary: Moonpay integrates PayPal as a fiat on-ramp on its platform in the UK and the EU, enabling users to purchase cryptocurrencies easily. This expansion excludes users in Hungary, Croatia, and Iceland, but will be fully rolled out soon. Moonpay customers can now buy and trade over 110 cryptocurrencies via the PayPal integration.

Full article
2024-06-17T07:48:27Z
PepsiCo: This Dividend King Just Triggered A Strong Buy Signal (PEP) | Seeking Alpha very bullish
PEP

Summary: PepsiCo (PEP) stock has seen a significant pullback to around $163 per share, reaching a key support level at the 200-week simple moving average, presenting a buying opportunity for investors. The company is a 'Dividend King' with a track record of increasing dividends for over 50 years, making it an attractive option for dividend-focused investors. Earnings estimates for PepsiCo show an attractive valuation compared to competitor Coca-Cola, and the company's strong balance sheet includes an investment grade credit rating.

Full article
2024-06-17T07:47:26Z